73
Participants
Start Date
February 15, 2024
Primary Completion Date
December 11, 2024
Study Completion Date
December 11, 2024
Placebo (placebo matching zibotentan capsule and placebo matching dapagliflozin tablet)
"placebo capsule (matching zibotentan capsule)~placebo tablet (matching dapagliflozin tablet)"
Zibotentan + placebo (placebo matching dapagliflozin tablet)
"zibotentan capsule~placebo tablet (matching dapagliflozin tablet)"
Zibotentan + dapagliflozin
"zibotentan capsule~dapagliflozin 10 mg tablet"
Research Site, Kogarah
Research Site, Mechelen
Research Site, Mitcham
Research Site, Adelaide
Research Site, Milan
Research Site, Charleston
Research Site, Padua
Research Site, Tübingen
Research Site, San Antonio
Research Site, Englewood
Research Site, Bratislava
Research Site, Trnava
Research Site, Liberec
Research Site, Mladá Boleslav
Research Site, Prague
Research Site, Leipzig
Research Site, Roma
Research Site, Gifu
Research Site, Kawasaki-shi
Research Site, Kitakyusyu-shi
Research Site, Nagaoka-shi
Research Site, Niigata
Research Site, Sapporo
Research Site, Yokohama
Research Site, Bydgoszcz
Research Site, Katowice
Research Site, Mysłowice
Research Site, Poznan
Research Site, Nitra
Research Site, Aberdeen
Research Site, Hull
Research Site, Ipswich
Research Site, London
Research Site, Nottingham
Lead Sponsor
AstraZeneca
INDUSTRY